Pfizer "Disappointed" with First Results for Alzheimer's Drug Candidate
Amyloid-recognizing drug has no effect in patients with a high-risk genetic background.
Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?